Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Getting a breast explant

00:10:09

Getting a breast explant

Moncrieff

00:10:09


What to do about the mouse-inf...

00:07:43

What to do about the mouse-infested and worsening state of the Palace of Westminster?

Moncrieff

00:07:43


You have heard of Dyslexia but...

00:08:53

You have heard of Dyslexia but what is Dysgraphia?

Moncrieff

00:08:53


Should you embrace your digita...

00:09:48

Should you embrace your digital life and make it part of your remembrance after you pass ?

Moncrieff

00:09:48